Indicaciones: Deficiencia de carnitina primaria o secundaria, enfermedades metablicas, condiciones como dilisis renal que pueden afectar los niveles de carnitina
Patients should follow specific storage instructions provided with their medication and never freeze or expose peptides to extreme temperatures
Expected 12-month results include 15 to 22% body weight loss (50 to 75 pounds for a 300-pound person), 5 to 8 inch waist circumference reduction, major improvement in mobility and physical function, and often dramatic improvement or resolution of obesity-related health conditions including sleep apnea, fatty liver disease, and joint pain
In step 3, the 6-phosphogluconate is decarboxylated by 6-phosphogluconate dehydrogenase, in the process producing more NADPH, as well as the five-carbon sugar, ribulose-5-phosphate
By targeting these mechanisms, GLP-1 medications can help patients achieve significant weight loss and manage related metabolic conditions